Document is current

Article History

Received: 10 February 2022

Accepted: 22 March 2022

First Online: 4 April 2022

Declarations

:

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

: Informed consent was obtained from all individual participants included in the study.

: E.L. reports receiving grants from AIRC (Associazione Italiana per la Ricerca sul Cancro) and from the Italian Ministry of Health and faculty remuneration from ESMIT (European School of Multimodality Imaging and Therapy) and MI&T congressi. R. J.H. is on the Scientific Advisory Board of Telix Pharmaceuticals with any honoraria donated to his institution, he is a stock holder in this company, and he is also an honorary Trustee of the International Cancer Imaging Society and honorary Board Member of Neuroendocrine Cancer Australia. W.A.W. has been on the advisory boards and receives compensation from Blue Earth Diagnostics. N.P. declares honoraria from Actinium Pharmaceuticals, AstraZeneca/MedImmune; Consulting or Advisory Role from Illumina, progenics; Speakers' Bureau from Actinium Pharmaceuticals; Research Funding from Bayer Health; Bristol-Myers Squibb; Clarity Pharmaceuticals; Imaginab; Janssen; Regeneron; Travel, Accommodations Expenses from Bayer. The other authors declare no conflicts of interest.